Sydney：12/24 22:26:56

Tokyo：12/24 22:26:56

Hong Kong：12/24 22:26:56

Singapore：12/24 22:26:56

Dubai：12/24 22:26:56

London：12/24 22:26:56

New York：12/24 22:26:56

Live Updates  >  Live Update Details

2026-04-17 10:10:30

[Senate Democratic Report: Trump's Drug Price Deal Failed to Stop Drug Price Hikes, Pharmaceutical Companies' Profits Soar] (1) US President Trump has repeatedly stated that his agreement with pharmaceutical companies will lower prescription drug prices in the United States. (2) However, a report released by Senate Democrats (published by Bernie Sanders before the drug pricing hearing) found that companies that signed pricing agreements with Trump actually raised the prices of hundreds of drugs and launched new drugs with an average annual price of $353,000, including expensive gene therapies, cancer drugs, and multiple sclerosis drugs. (3) The report also pointed out that these companies' profits increased significantly during Trump's presidency, with total profits reaching $177 billion in 2025, up from $107 billion in 2024.

Real-Time Popular Commodities

Instrument Current Price Change

XAU

 4799.22

8.56

(0.18%)

XAG

 78.946

0.545

(0.70%)

CONC

 89.50

-1.67

(-1.83%)

OILC

 98.06

0.11

(0.11%)

USD

 98.225

0.026

(0.03%)

EURUSD

 1.1782

0.0001

(0.01%)

GBPUSD

 1.3518

-0.0007

(-0.05%)

USDCNH

 6.8250

0.0035

(0.05%)

Hot News

A summary chart of futures company viewpoints: Non-ferrous metals (copper, zinc, aluminum, nickel, tin, etc.) on April 17th

04-17 13:25

The hidden nature of Federal Reserve Chairman nominee Warsh's vast assets presents new challenges for ethical review.

04-17 13:23

Oil price movements face significant two-way risks.

04-17 13:20

A chart: A summary of "pivot points + long/short position signals" for gold, crude oil, forex, and stock indices on April 17, 2026.

04-17 12:06

Risk Disclosure
Trading stocks, currencies, commodities, futures, bonds, funds or cryptocurrencies involves significant risks. These risks include the loss of part or all of your investment capital, so trading is not suitable for all investors. Before making any financial decision, you should conduct your own due diligence, use your own judgment, and consult a qualified advisor. The content on this website is not specifically directed at you, nor have we considered your financial situation or needs. Information provided on this site may not be real-time or accurate. Prices shown on this website may be provided by market makers rather than exchanges. You are solely responsible for any trades or financial decisions made based on the information from this site, and you must not rely on such information. We make no guarantees regarding any information on the website and assume no responsibility for any trading losses caused by the use of this information. Use, storage, copying, display, modification, dissemination or distribution of the data contained on this site is prohibited without prior written permission. All intellectual property rights in the data provided on this site are reserved by the respective data providers and exchanges.

TURBOFIN TECHNOLOGIES PTY LTD Copyright © 2025 FXBus Ltd